INHALANT GLUCOCORTICOID APPLICATION EXPERIENCE AMONG INFANTS WITH BRONCHOPULMONARY DYSPLASIA IN THE FIRST HALF YEAR OF LIFE
Abstract
The article describes the modern views on the application of the inhalant glucocorticoids (budesonide suspension) among infants, who underwent artificial pulmonary ventilation at the neonatal stage and who had bronchopulmonary dysplasia formed. The authors performed the clinical and functional evaluation of their state owing to the bronchophonography along with the follow up observation until 6 month of life.
Key words: artificial pulmonary ventilation, bronchopulmonary dysplasia, extremely low body weight, bronchophonography, acoustic work of breathing.
Key words: artificial pulmonary ventilation, bronchopulmonary dysplasia, extremely low body weight, bronchophonography, acoustic work of breathing.
About the Authors
I.V. Davydova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
G.V. Yatsyk
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
O.F. Lukina
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
O.V. Tresorukova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Davydova I., Yatsyk G., Lukina O., Tresorukova O. INHALANT GLUCOCORTICOID APPLICATION EXPERIENCE AMONG INFANTS WITH BRONCHOPULMONARY DYSPLASIA IN THE FIRST HALF YEAR OF LIFE. Pediatric pharmacology. 2008;5(6):42-44.
Views:
420
Email this article 